Efficacy of Ultrasound-assisted Caudal Epidural Pulsed Radiofrequency for Anal Pain in Cancer Patients,

Assiut University40 enrolled

Overview

Our primary goal will be to investigate the analgesic efficacy of ultrasound (US)-assisted caudal epidural PRF (pulsed radiofrequency)( stimulation in patients with perineal or anal pain cancer patients using (visual analog scale (VAS) scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks; secondary outcomes will be the effects on opioid use and total opioid use in the 24 h, quality of life, patient satisfaction and opioid and intervention related side effects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Perineal Pain

Interventions

US assisted caudal epidural pulsed radiofrequencyPROCEDURE

patients will receive US assisted caudal epidural pulsed radiofrequency and followed up to 8 weeks

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * American Society of Anesthesiology physical status of I or III (ASA), of both sex * cancer-related anal or perineal pain Exclusion Criteria: * coagulopathies * allergies to the contrast dye * patients with moderate or significant cardiac/respiratory disease or hepatic

Locations (1)

South Egypt Cancer instIitute

Asyut, Egypt

RECRUITING

Outcomes

Primary Outcomes

visual analog scale (VAS) score 4 weeks post-intervention

Our primary goal will be to investigate the analgesic efficacy of ultrasound-assisted caudal epidural PRF stimulation in patients with perineal or anal pain cancer patients using VAS scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks

Time frame: 8 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.